Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020

Pre-vaccine SARS-CoV-2 seroprevalence data from Germany are scarce outside hotspots, and socioeconomic disparities remained largely unexplored. The nationwide representative RKI-SOEP study (15,122 participants, 18–99 years, 54% women) investigated seroprevalence and testing in a supplementary wave o...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuhauser, Hannelore, Rosario, Angelika Schaffrath, Butschalowsky, Hans, Haller, Sebastian, Hoebel, Jens, Michel, Janine, Nitsche, Andreas, Poethko-Müller, Christina, Prütz, Franziska, Schlaud, Martin, Steinhauer, Hans W., Wilking, Hendrik, Wieler, Lothar H., Schaade, Lars, Liebig, Stefan, Gößwald, Antje, Grabka, Markus M., Zinn, Sabine, Ziese, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662125/
https://www.ncbi.nlm.nih.gov/pubmed/36376417
http://dx.doi.org/10.1038/s41598-022-23821-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662125/
https://www.ncbi.nlm.nih.gov/pubmed/36376417
http://dx.doi.org/10.1038/s41598-022-23821-6

Ejemplares similares